Pfizer Announced as Platinum Sponsor of Pharma Integrates

Life Sciences Index is delighted, once again, to welcome Pfizer as platinum sponsor of this year's Pharma Integrates (PI) event. With the milestone fifth edition of the debate-led congress fast approaching, Pfizer's Michael O'Brien, Vice President, Technology & Innovation, commented: "We believe that, in today's world, open innovation, together with cross-industry debate and collaboration, is critical to the successful development of game-changing technology advances. At Pfizer, we are committed to bringing forward leading-edge technologies that ensure global patient access, accelerate time to market and provide patients with effective and well-tolerated medicinal outcomes."

"During the past few years, Pharma Integrates has proven to be a successful forum for discussing major industry trends, sharing the challenges faced by global healthcare systems, and providing insightful perspectives regarding how others in industry, academia and government are coping with this complex ecosystem," he added.

The roundtable-based event, as in previous years, offers an open, interactive and challenging environment for discussion and deliberation. Under the main theme of Shaping Pharma's Future, attendees will engage with current topics such as precision medicine, disruptive thinking in pharmaceutical regulation, patient compliance, future pharma supply chains, connected healthcare and more.

In addition, the milestone fifth edition will, for the first time, include both plenary panel discussions and interviews, adding a new dimension to the event. Senior pharmaceutical leaders Sir John Bell, Regius Professor of Medicine at Oxford University, and Guido Rasi, Executive Director, European Medicines Agency, will be taking questions from the show floor.

Adding to the interactive structure of PI, this year also sees the introduction of a new mobile app, which will maximize attendee engagement and facilitate live polling, presentation sharing and snapshot micro surveys. Plus, with more than 70 outstanding speakers from across the entire pharmaceutical spectrum, there's going to be a lot to talk about! So don't delay, book today and have your say. Early bird delegate rates are available for a very limited time.